Comparing Treatment Efficacy With Mepolizumab and Omalizumab in Severe Asthma - "Choosebetweenamab".
Clinical trial NCT04585997 · UNKNOWN
Trial details
- NCT number
- NCT04585997
- Sponsor
- University of Newcastle, Australia
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-03
- Primary completion
- 2022-06-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.